BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma.

Saved in:
Bibliographic Details
Title: BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma.
Authors: Ferdinandus J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Müller H; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Jablonski J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Kerkhoff A; Department for Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Muenster, 48149 Muenster, Germany., Scholl S; Klinik für Innere Medizin II, Jena University Hospital, Jena, Germany., Ko YD; Department of Internal Medicine, Johanniter Hospital, Bonn, Germany., Topp MS; Department of Internal Medicine II, Hematology and Oncology, University Hospital Wuerzburg, Wuerzburg, Germany., Vucinic V; Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Germany., Jung W; Department of Haematology and Oncology, Göttingen, Germany., Schroers R; Knappschaftskrankenhaus Bochum, University Hospital Bochum, Bochum, Germany., Rank A; Department of Internal Medicine II, University Hospital Augsburg, Augsburg, Germany., Fuchs M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Schneider G; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Diehl V; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Borchmann P; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany., Behringer K; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany.; German Hodgkin Study Group (GHSG), Cologne, Germany.
Source: JAMA oncology [JAMA Oncol] 2026 Apr 01; Vol. 12 (4), pp. 415-417.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2374-2445
DOI:10.1001/jamaoncol.2025.6327